| Literature DB >> 29379488 |
Tze Y Thung1, Son Radu1,2, Nor A Mahyudin1, Yaya Rukayadi1, Zunita Zakaria3, Nurzafirah Mazlan4, Boon H Tan5, Epeng Lee1,2, Soo L Yeoh1,2, Yih Z Chin1, Chia W Tan1, Chee H Kuan6, Dayang F Basri7, Che W J Wan Mohamed Radzi8.
Abstract
The aim of the present study was to investigate the prevalence of Salmonella spp., Salmonella Enteritidis and Salmonella Typhimurium in retail beef from different retail markets of Selangor area, as well as, to assess their pathogenic potential and antimicrobial resistance. A total of 240 retail beef meat samples (chuck = 60; rib = 60; round = 60; sirloin = 60) were randomly collected. The multiplex polymerase chain reaction (mPCR) in combination with the most probable number (MPN) method was employed to detect Salmonella spp., S. Enteritidis and S. Typhimurium in the meat samples. The prevalence of Salmonella spp., S. Enteritidis and S. Typhimurium in 240 beef meat samples were 7.50, 1.25, and 0.83%, respectively. The microbial loads of total Salmonella was found in the range of <3 to 15 MPN/g. Eight different serovars of Salmonella were identified among the 23 isolates, and S. Agona was the predominant serovar (26.09%). Interestingly, all the Salmonella isolates were resistant to penicillin, erythromycin and vancomycin, but the sensitivity was observed for tetracycline, gentamicin and amoxicillin/clavulanic acid. All 23 isolates were resistant to at least three antibiotics. Two S. Typhimurium isolates (8.70%) exhibited the highest multiple antibiotic resistance (MAR) index value of 0.56 which shown resistance to nine antibiotics. PCR analysis of virulence genes showed that all Salmonella isolates (100%) were positive for the invA gene. Meanwhile, pefA was only identified in S. Enteritidis and S. Typhimurium. The findings in this study indicate that retail beef products tested were widely contaminated with multi-drug resistant (MDR) Salmonella and various virulence genes are present among the isolated Salmonella serovars.Entities:
Keywords: Salmonella; antimicrobial resistance; beef meat; multiplex PCR; prevalence; virulence gene
Year: 2018 PMID: 29379488 PMCID: PMC5770799 DOI: 10.3389/fmicb.2017.02697
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
PCR primers used for amplification of virulence genes in Salmonella isolates.
| F- TATCGCCACGTTCGGCAA | 275 | Nayak et al., | |
| R- TCGCACCGTCAAAGGAACC | 700 | Murugkar et al., | |
| F- TGTTTCCGGGCTTGTGCT | 854 | Cardona-Castro et al., | |
| R- CAGGGCATTTGCTGATTCTTCC | 517 | Huehn et al., | |
| F- CGGAAGCTTATTTGCGCCATGCTGAGGTAG | 617 | Murugkar et al., | |
| R- GCATGGATCCCCGCCGGCGAGAT TGTG | 669 | Swamy et al., | |
| F- TCAGAAGRCGTCTAACCACTC | |||
| R- TACCGTCCTCATGCACACTC | |||
| F- TTGTGTCGCTATCACTGGCAACC | |||
| R- ATTCGTAACCCGCTCTCGTCC | |||
| F- CGGAAATACCATCAAATA | |||
| R- CCCAAACCCATACTTACTCTG |
Figure 1Representative amplification of random sequence, sdfI gene and fliC gene for identification of Salmonella spp. (429 bp), S. Enteritidis (304 bp) and S. Typhimurium (620 bp), respectively. Lane M: 100-bp DNA ladder; Lane 1: mixture of Salmonella spp. and S. Typhimurium (positive); Lane 2: Salmonella spp. and S. Enteritidis (positive); Lane 3 to Lane 8: meat samples examined; and Lane 9: negative control.
Prevalence of Salmonella spp., Salmonella Enteritidis and Salmonella Typhimurium in beef meat samples using MPN-mPCR method.
| Chuck | 30 | 3 (10.0%) | 0 (0.0%) | 0 (0.0%) | 30 | 2 (6.7%) | 0 (0.0%) | 0 (0.0%) |
| Rib | 30 | 3 (10.0%) | 0 (0.0%) | 0 (0.0%) | 30 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Round | 30 | 4 (13.3%) | 1 (3.3%) | 1 (3.3%) | 30 | 2 (6.7%) | 1 (3.3%) | 1 (3.3%) |
| Sirloin | 30 | 2 (6.7%) | 1 (3.3%) | 0 (0.0%) | 30 | 2 (6.7%) | 0 (0.0%) | 0 (0.0%) |
| Total | 120 | 12 (10.0%) | 2 (1.7%) | 1 (0.8%) | 120 | 6 (5.0%) | 1 (0.8%) | 1 (0.8%) |
Number of samples.
Percentage of positive samples.
Microbial loads of Salmonella spp., Salmonella Enteritidis and Salmonella Typhimurium (MPN/g) in beef meat samples using MPN-mPCR method.
| Chuck | <3 | <3 | 7.4 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | 3.6 | <3 | <3 | <3 | <3 | <3 | <3 |
| Rib | <3 | <3 | 7.4 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | <3 | <3 |
| Round | <3 | <3 | 15 | <3 | <3 | 3.6 | <3 | <3 | 3.6 | <3 | <3 | 3.6 | <3 | <3 | 3.6 | <3 | <3 | 3.6 |
| Sirloin | <3 | <3 | 3.6 | <3 | <3 | 3.6 | <3 | <3 | <3 | <3 | <3 | 3.6 | <3 | <3 | <3 | <3 | <3 | <3 |
Minimum MPN/g value.
Median MPN/g value.
Maximum MPN/g value.
Antimicrobial susceptibility pattern of Salmonella isolates.
| Amoxycillin (30 μg) | 23 | 4 (17.39) | 4 (17.39) | 15 (65.22) |
| Ampicillin (10 μg) | 23 | 11 (47.83) | 8 (34.78) | 4 (17.39) |
| Amoxicillin/Clavulanic acid (30 μg) | 23 | – | – | 23 (100) |
| Cephazolin (30 μg) | 23 | 2 (8.70) | 2 (8.70) | 19 (82.60) |
| Ceftazidime (30 μg) | 23 | – | 5 (21.74) | 18 (78.26) |
| Chloramphenicol (30 μg) | 23 | 7 (30.43) | 13 (56.52) | 3 (13.05) |
| Ciprofloxacin (5 μg) | 23 | 5 (21.74) | 5 (21.74) | 13 (56.52) |
| Erythromycin (15 μg) | 23 | 23 (100) | – | – |
| Gentamicin (10 μg) | 23 | – | – | 23 (100) |
| Kanamycin (30 μg) | 23 | – | 2 (8.70) | 21 (91.30) |
| Penicillin (10 μg) | 23 | 23 (100) | – | – |
| Nalidixic acid (30 μg) | 23 | – | 2 (8.70) | 21 (91.30) |
| Streptomycin (10 μg) | 23 | – | 2 (8.70) | 21 (91.30) |
| Suphamethoxazole/trimethoprim (25 μg) | 23 | 4 (17.39) | 6 (26.09) | 13 (56.52) |
| Tetracycline (30 μg) | 23 | – | – | 23 (100) |
| Vancomycin (30 μg) | 23 | 23 (100) | – | – |
The antibiotic resistance profile patterns and multiple antibiotic resistance (MAR) index of Salmonella isolates.
| 1 | Wet market | Round | AMP, C, E, P, SXT, VA | 0.38 | |
| 2 | Wet market | Sirloin | AMP, C, E, P, VA | 0.31 | |
| 3 | Wet market | Round | AML, AMP, KZ, C,CIP, E, P, SXT, VA | 0.56 | |
| 4 | Wet market | Chuck | AMP, E, P, VA | 0.25 | |
| 5 | Wet market | Rib | AMP, E, P, VA | 0.25 | |
| 6 | Wet market | Rib | AMP, E, P, VA | 0.25 | |
| 7 | Wet market | Rib | AMP, E, P, VA | 0.25 | |
| 8 | Wet market | Round | E, P, VA | 0.19 | |
| 9 | Wet market | Round | E, P, VA | 0.19 | |
| 10 | Wet market | Sirloin | E, P, VA | 0.19 | |
| 11 | Wet market | Chuck | E, P, VA | 0.19 | |
| 12 | Wet market | Chuck | E, P, VA | 0.19 | |
| 13 | Wet market | Round | CIP, E, P, VA | 0.25 | |
| 14 | Wet market | Round | CIP, E, P, VA | 0.25 | |
| 15 | Wet market | Sirloin | E, P, VA | 0.19 | |
| 16 | Hypermarket | Round | AMP, C, E, P, SXT, VA | 0.38 | |
| 17 | Hypermarket | Round | AML, AMP, KZ, C, CIP, E, P, SXT, VA | 0.56 | |
| 18 | Hypermarket | Chuck | AMP, E, P, VA | 0.25 | |
| 19 | Hypermarket | Round | AMP, E, P, VA | 0.25 | |
| 20 | Hypermarket | Chuck | E, P, VA | 0.19 | |
| 21 | Hypermarket | Round | CIP, E, P, VA | 0.25 | |
| 22 | Hypermarket | Sirloin | AML, C, E, P, VA | 0.31 | |
| 23 | Hypermarket | Sirloin | AML, C, E, P, VA | 0.31 |
AML, Amoxycillin; AMP, Ampicillin; KZ, Cephazolin; C, Chloramphenicol; CIP, Ciprofloxacin; E, Erythromycin; P, Penicillin; SXT, Suphamethoxazole/trimethoprim; VA, Vancomycin.
Virulence genes profiles of Salmonella isolates.
| 3 | 2 | 6 | 3 | 3 | 3 | 1 | 2 | 23 (100) | |
| 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 3 (13.04) | |
| 3 | 2 | 4 | 3 | 3 | 1 | 1 | 2 | 19 (82.61) | |
| 2 | 1 | 6 | 1 | 0 | 2 | 0 | 2 | 14 (60.87) | |
| 3 | 1 | 3 | 1 | 2 | 3 | 1 | 2 | 16 (69.57) | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 (0) | |